In a quarterly disclosure filed on July 7, 2026, value investor Robert Olstein's firm, Olstein Capital Management, revealed it had sold its entire stake in Avantor, Inc. The sale involved all 1.21 million shares the firm held in the life sciences company. As with all 13F filings, this report is delayed and reflects the firm's holdings as of the end of the second quarter, on June 30, 2026.
The transaction occurred before Avantor reported second-quarter earnings on July 29 that beat analyst expectations and sent its stock higher. [1, 4] The reporting period also coincided with the acquisition of Olstein Capital Management's mutual fund business by Easterly Asset Management, which was completed in late June 2026. [6, 7] Olstein is known for a value-oriented investment philosophy focused on free cash flow and rigorous accounting analysis. [12, 18]